Market Closed - Nyse 04:00:02 2024-04-25 pm EDT 5-day change 1st Jan Change
8.97 USD -6.95% Intraday chart for Paragon 28, Inc. -7.05% -27.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Slump Late Afternoon MT
Sector Update: Health Care MT
Paragon 28 Shares Slump After Announcing Preliminary Q1 Revenue, CFO Resignation MT
Paragon 28, Inc. Reaffirms Net Revenue Guidance for Fiscal Year 2024 CI
Paragon 28, Inc. Announces Chief Financial Officer Changes CI
Paragon 28, Inc. Announces Board Changes CI
Paragon 28, Inc. Provides Revenue Guidance for the First Quarter 2024 CI
Paragon 28, Inc. Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler®? R3INFORCE?? Extraosseous Repair System CI
Paragon 28 Insider Bought Shares Worth $255,226, According to a Recent SEC Filing MT
Needham Ups Price Target on Paragon 28 to $17 From $16, Keeps Buy Rating MT
Paragon 28 Narrows Q4 Loss, Revenue Increases; Sets 2024 Outlook MT
Transcript : Paragon 28, Inc., Q4 2023 Earnings Call, Feb 29, 2024
Earnings Flash (FNA) PARAGON 28 Reports Q4 Revenue $60.6M, vs. Street Est of $60.5M MT
Paragon 28, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Paragon 28, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Paragon 28, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Paragon 28, Inc. Launches Precision®? Mis Bunion System Offering Surgeons A Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions CI
Paragon 28, Inc. Announces the Launch of the FJ2000? Power Console and Burr System Designed Specifically for Foot and Ankle Procedures CI
Paragon 28, Inc. Launches the Mister Tendon? Harvester System ? the First and Only Minimally Invasive Harvesting System for Fhl and Fdl Tendon Transfer Procedures CI
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic? ? A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures CI
Transcript : Paragon 28, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM
Paragon 28, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023 CI
Paragon 28, Inc. Announce the Launch of the Grappler Knotless Anchor System and Bridgeline Tape CI
Paragon 28, Inc. Launches Beast Cortical Fibers CI
Paragon 28 Launches Jaws Great White Staple System Further Expanding Its Nitinol Staple Offering CI
Chart Paragon 28, Inc.
More charts
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
8.97 USD
Average target price
18 USD
Spread / Average Target
+100.67%
Consensus
  1. Stock Market
  2. Equities
  3. FNA Stock
  4. News Paragon 28, Inc.
  5. Paragon 28 : Prices IPO at $16 Per Share